Venus Remedies Limited (VENUSREM.NS) - Quarterly Income Statement

Home
VENUSREM.NS
Financials

343.5 (INR) • At close September 19, 2024

Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

	2024 Q1	2023 Q4	2023 Q3	2023 Q2	2023 Q1	2022 Q4	2022 Q3	2022 Q2	2022 Q1	2021 Q4	2021 Q3	2021 Q2	2021 Q1	2020 Q4	2020 Q3	2020 Q2	2020 Q1	2019 Q4	2019 Q3	2019 Q2	2019 Q1	2018 Q4	2018 Q3	2018 Q2	2018 Q1	2016 Q4	2013 Q4	2013 Q3	2013 Q1	2012 Q4	2012 Q3	2012 Q2	2012 Q1
Revenue Numbers are in millions	1,086.1	1,951.6	1,434.2	1,677.2	951.5	1,556.4	1,169	1,398.9	1,430.8	1,419.347	1,243.44	2,025.6	1,298.11	1,113.715	1,219.38	1,260.69	1,887.45	782.33	968.59	878.94	736.46	860.749	760.11	883.88	669.42	798.21	1,526.115	1,312.61	1,266.45	1,338.736	1,116.24	1,104.11	1,120.34
Cost of Revenue Numbers are in millions	818.2	1,456.6	1,130.8	975.2	479.4	869.7	703.3	875.3	861.7	1,080.027	747.73	1,360.99	793.61	862.188	688.52	765.99	1,199.88	448.555	551.09	471.03	378.22	673.126	433.95	472.23	345	422.43	908.714	694.88	749.7	813.477	635.9	620.28	622.62
Gross Profit Numbers are in millions	267.9	495	303.4	702	472.1	686.7	465.7	523.6	569.1	339.32	495.71	664.61	504.5	251.527	530.86	494.7	687.57	333.775	417.5	407.91	358.24	187.623	326.16	411.65	324.42	375.78	617.401	617.73	516.75	525.259	480.34	483.83	497.72
Gross Profit Ratio Numbers are in millions	0.247	0.254	0.212	0.419	0.496	0.441	0.398	0.374	0.398	0.239	0.399	0.328	0.389	0.226	0.435	0.392	0.364	0.427	0.431	0.464	0.486	0.218	0.429	0.466	0.485	0.471	0.405	0.471	0.408	0.392	0.43	0.438	0.444
Reseach & Development Expenses Numbers are in millions	45.8	47.8	27.2	44.2	39.3	47.7	59.3	56.7	65.2	80.029	46.91	74.98	28.38	3.639	36.39	42.04	36.63	43.913	35.54	28.29	34.78	48.33	33.36	32.34	32.5	0	0	0	0	0	0	0	0
General & Administrative Expenses Numbers are in millions	169.3	312.7	221.2	294.8	169.4	-437.546	172.1	0	0	91.076	0	0	0	111.636	0	0	0	104.643	0	0	0	56.725	0	0	0	0	0	0	0	-399.142	133.09	141.9	148.8
Selling & Marketing Expenses Numbers are in millions	0	-1.1	0	294.8	169.4	247.9	172.1	187.2	193.8	-76.926	192.24	191.6	180.18	-87.825	193.6	227.31	327.21	-5.558	158.17	147.77	117.23	-35.594	145.69	112.95	91.02	0	0	0	0	0	0	0	0
SG&A Numbers are in millions	169.3	311.6	221.2	294.8	169.4	247.9	172.1	187.2	193.8	14.15	192.24	191.6	180.18	23.811	193.6	227.31	327.21	99.085	158.17	147.77	117.23	21.131	145.69	112.95	91.02	66.1	0	0	0	-109.765	133.09	141.9	148.8
Other Expenses Numbers are in millions	15.9	39.2	23.5	30.5	22.6	32.8	38.1	17.9	14.4	-49.825	12.16	28.9	19.54	-31.249	18.27	122.76	20.35	-15.685	17.73	13.45	8.23	-23.189	8.6	31.32	5.89	0	378.897	356.14	8.18	417.61	124.87	131.12	128.15
Operating Expenses Numbers are in millions	215.1	359.4	248.4	588.5	443.6	523.5	456.9	483.8	502	359.506	457.77	478.65	422.43	300.378	437.01	474.31	567.95	323.151	394.33	366.48	345.4	256.829	361.87	335.62	310.08	287.54	378.897	356.14	296.03	307.845	257.96	273.02	276.95
Operating Income Numbers are in millions	52.8	135.6	55	144	28.5	196	46.9	57.7	67.1	-76.161	126.04	214.86	82.07	-48.851	93.85	20.39	119.62	10.624	23.17	41.43	12.84	-69.206	-35.71	76.03	14.34	88.24	199.38	178.16	220.72	217.414	222.38	210.81	220.77
Operating Income Ratio Numbers are in millions	0.049	0.069	0.038	0.086	0.03	0.126	0.04	0.041	0.047	-0.054	0.101	0.106	0.063	-0.044	0.077	0.016	0.063	0.014	0.024	0.047	0.017	-0.08	-0.047	0.086	0.021	0.111	0.131	0.136	0.174	0.162	0.199	0.191	0.197
Total Other Income Expenses Net Numbers are in millions	15.7	39	22.8	-0.6	22	1.3	-1.5	17.9	11.8	78.472	-3.12	-0.27	18.13	230.835	44.79	124.77	-99.89	-56.289	-22.93	-35.63	-53.57	-46.472	-87.13	-76.82	-72.29	-80.03	-39.123	-83.43	-58.63	-60.204	-52.94	-53.72	-76.15
Income Before Tax Numbers are in millions	68.5	174.6	77.8	143.4	50.5	197.3	45.4	57.7	78.9	2.311	46.98	214.59	100.2	181.984	138.64	145.16	19.73	-45.665	0.24	5.8	-40.73	-115.678	-122.84	-0.79	-57.95	8.21	199.381	178.16	162.09	157.21	169.44	157.09	144.62
Income Before Tax Ratio Numbers are in millions	0.063	0.089	0.054	0.085	0.053	0.127	0.039	0.041	0.055	0.002	0.038	0.106	0.077	0.163	0.114	0.115	0.01	-0.058	0	0.007	-0.055	-0.134	-0.162	-0.001	-0.087	0.01	0.131	0.136	0.128	0.117	0.152	0.142	0.129
Income Tax Expense Numbers are in millions	56.3	69.6	9.3	44	38.7	86.7	12.5	4.4	10	-0.021	-9.48	-16.89	-16.77	-169.11	22.09	14.9	20.35	8.149	9.85	1.64	8.23	-1.02	-5.54	-4.93	5.89	37.04	24.822	5.88	8.97	36.038	8.89	6.17	4.17
Net Income Numbers are in millions	12.2	105.2	68.5	99.4	11.8	110.558	32.9	53.3	68.9	2.332	56.5	231.5	117	351.094	116.55	130.26	19.73	-53.803	-9.62	4.16	-40.73	-114.647	-117.3	4.14	-57.95	45.25	174.558	172.28	153.12	121.173	160.55	150.92	140.45
Net Income Ratio Numbers are in millions	0.011	0.054	0.048	0.059	0.012	0.071	0.028	0.038	0.048	0.002	0.045	0.114	0.09	0.315	0.096	0.103	0.01	-0.069	-0.01	0.005	-0.055	-0.133	-0.154	0.005	-0.087	0.057	0.114	0.131	0.121	0.091	0.144	0.137	0.125
EPS Numbers are in millions	0.91	7.86	5.12	7.44	0.88	8.27	2.46	3.99	5.16	0.18	4.22	17.32	8.86	28.44	9.44	10.55	1.6	-4.37	-0.78	0.34	-3.3	-9.3	-9.5	0.34	-4.7	3.94	14.14	15.06	53.53	9.68	16.48	15.49	14.42
EPS Diluted Numbers are in millions	0.91	7.86	5.12	7.44	0.88	8.27	2.46	3.99	5.16	0.18	4.22	17.32	8.86	28.44	9.44	10.55	1.6	-4.36	-0.78	0.34	-3.3	-9.29	-9.5	0.34	-4.7	3.94	14.14	15.06	53.53	9.68	16.48	15.49	14.42
EBITDA Numbers are in millions	112.6	194.7	120.4	208.4	126.6	278.9	119.1	147.6	159.5	75.109	136.53	301.94	187.84	19.788	199.09	229.24	225.86	140.867	125.67	140.52	106.06	-2.298	57.94	192.72	104.94	176.681	342.783	358.76	316.07	283.901	302.47	290.58	298.46
EBITDA Ratio Numbers are in millions	0.104	0.1	0.084	0.124	0.133	0.179	0.102	0.106	0.111	0.053	0.11	0.149	0.145	0.018	0.163	0.182	0.12	0.18	0.13	0.16	0.144	-0.003	0.076	0.218	0.157	0.221	0.225	0.273	0.25	0.212	0.271	0.263	0.266

Venus Remedies Limited

NSE:VENUSREM.NS Add to watchlist

NSE:VENUSREM.NS